CJC-1295 is a GHRH analog investigated in research for sustained growth hormone stimulation. Preclinical and early clinical studies have examined its effects on GH/IGF-1 axis activation, leading to potential applications in models of growth deficiency, muscle wasting, and metabolic regulation. It is studied for long-acting endocrine modulation in laboratory protocols.
For research use only.
